BioMed Realty Trust, Inc. is a real estate firm operating in the US and the UK which owns some of the most expensive properties in the Cambridge MA area. As of 2011, BioMed owns the 301 Binney Street building, which has "approximately 417,300 rentable square feet of office and laboratory space" and which BioMed leases to Ironwood Pharmaceuticals, Inc., the Broad Institute of Harvard and MIT, and Living Proof, Inc. BioMed also owns the 320 Bent Street facility, which "comprises approximately 184,400 rentable square feet of laboratory and office space which is approximately 79% leased to Merck & Co., Inc."
BioMed Realty Trust, Inc. and other real estate firms like it contribute to the commodification of land and the rise in property values and rental costs, facilitating the ongoing mass displacement of Black and Brown working class residents from the Boston area ('gentrification'). By leasing space to companies which support the US military and companies that use patent regimes to maximize profits while depriving lifesaving medical treatments to populations in the Global South, BioMed Realty Trust, Inc. is also deeply complicit in US Empire and global medical apartheid.
2 links
BioMed Realty Trust, Inc. is an international real estate firm which owns some of the most expensive properties in the Cambridge MA area. As of 2011, BioMed Realty owns the 320 Bent Street facility that "comprises approximately 184,400 rentable square feet of laboratory and office space which is approximately 79% leased to Merck & Co., Inc."
BioMed Realty Trust, Inc. is a real estate firm which owns some of the most expensive properties in the Cambridge area.. As of 2011, BioMed owns the 301 Binney Street building that has "approximately 417,300 rentable square feet of office and laboratory space," a portion of which is leased to the Broad Institute of Harvard and MIT. BioMed Realty has also leased space to big pharma companies like Merck.